The Alliance for Clean Air, launched by the World Economic Forum and the Clean Air Fund, published a practical guide on how businesses can quantify the air pollutant emissions along their value chains The Alliance for Clean Air has adopted … Read the full press release
Posted in Business, Energy, Gas & Oil, Environment, Industrial, Management, Switzerland
Tagged air pollution, air pollution footprint, Andreas Ahrens, Claire Lund, Clean Air Fund, Climate and Clean Air Coalition, climate change conference, COP26, EY, GEA Group, GlaxoSmithKline, GSK, Haleon, Inter IKEA Group, Moderna, Oracle, Pim Valdre, Stockholm Environment Institute, sustainability, The Alliance for Clean Air, World Economic Forum
La Alianza para el Aire Limpio, lanzada por el Foro Económico Mundial y el Fondo de Aire Limpio, publicó una guía práctica sobre cómo las empresas pueden cuantificar las emisiones de contaminantes del aire a lo largo de sus cadenas … Read the full press release
Posted in Business, Energy, Gas & Oil, Environment, Industrial, Management, Switzerland
Tagged Andreas Ahrens, Claire Lund, Coalición para el Clima y el Aire Limpio, conferencia sobre el cambio climático, contaminación del aire, COP26, EY, Fondo de Aire Limpio, Foro Económico Mundial, GlaxoSmithKline, Grupo GEA, Grupo Inter IKEA, GSK, Haleon, huella de contaminación del aire, Instituto Ambiental de Estocolmo, La Alianza para el Aire Limpio, Moderna, Oracle, Pim Valdre, Sostenibilidad
(PRESS RELEASE) LONDON, 19-Apr-2022 — /EuropaWire/ — GlaxoSmithKline plc (LON: GSK), a British multinational science-led healthcare company, has announced the third major regulatory milestone for its daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for the potential treatment of … Read the full press release
(COMMUNIQUÉ DE PRESSE) LONDRES, 19-Apr-2022 — /EuropaWire/ — GlaxoSmithKline plc (LON : GSK), une multinationale scientifique britannique , a annoncé la troisième étape réglementaire majeure pour son daprodustat, un inhibiteur oral du facteur prolyl hydroxylase inductible par l’hypoxie (HIF-PHI), pour le … Read the full press release
Zulassungsantrag für die Behandlung von Anämie bei chronischer Nierenerkrankung basierend auf dem klinischen Phase-III-Studienprogramm ASCEND, bestehend aus fünf Studien, die alle ihre co-primären Wirksamkeits- und Sicherheitsendpunkte erreichten Die Zulassung der EMA-Anträge ist der erste große regulatorische Meilenstein für Daprodustat seit … Read the full press release
Posted in Healthcare, Marketing, Pharma & Biotech, United Kingdom
Tagged American Society of Nephrology, Anämie, ASCEND-D, ASCEND-ND, Behandlung von Anämie, chronische Nierenerkrankung, CKD, daprodustat, Dialyse, EMA, Europäische Arzneimittel-Agentur, GlaxoSmithKline, Hämoglobin, HIF-PHI, klinisches Studienprogramm ASCEND Phase III, MAA, Prolylhydroxylase-Hemmer, Zulassungsantrag
Submission for the treatment of anaemia of chronic kidney disease based on the ASCEND Phase III clinical trial programme, consisting of five trials that all met their co-primary efficacy and safety endpoints EMA file acceptance is the first major regulatory … Read the full press release
Posted in Healthcare, Marketing, News, Pharma & Biotech, United Kingdom
Tagged American Society of Nephrology, anaemia, ASCEND Phase III clinical trial programme, ASCEND-D, ASCEND-ND, Chronic kidney disease, CKD, daprodustat, dialysis, EMA, European Medicines Agency, GlaxoSmithKline, haemoglobin, HIF-PHI, MAA, Marketing Authorisation Application, prolyl hydroxylase inhibitor, treatment of anaemia
(PRESS RELEASE) BUCKINGHAMSHIRE, UK, 26-Oct-2021 — /EuropaWire/ — This year, Baltimore Innovations will be unveiling a new range of Humidity Balancing desiccants at Medica 2021. These HUMI-BALANCE™ Sachets are ideal for applications where products need to be protected not only … Read the full press release
Posted in Chemicals, Germany, Industrial, Marketing, News, Pharma & Biotech, Technology, United Kingdom
Tagged Alere, B-SURE™, Baltimore Innovations, Barrier Foil Pouches, BP, desiccants, GlaxoSmithKline, HUMI-BALANCE™ Sachets, Humidity Balancing desiccants, Matthew Valentine, Medica 2021, Medica Show, Moisture-control, OTC, pharmaceuticals, Philippe Depois, Silica Gel Sachets, SUPERDRYPAK™
(PRESS RELEASE) BUCKINGHAMSHIRE, UK, 26-Oct-2021 — /EuropaWire/ — Moisture-control experts Baltimore Innovations have just announced their participation at U-Tech 2021 – the leading exhibition for the global polyurethane industry. The show will run from 16th until 18th November 2021, at … Read the full press release
Posted in Chemicals, Industrial, Marketing, Netherlands, News, Technology, United Kingdom
Tagged 3A SUPERSIV® Paste, 3A SUPERSIV® Powder, 4A SUPERSIV® Paste, 4A SUPERSIV® Powder, adhesives, Akzo Nobel, Baltimore Innovations, BMW, BP, coatings, desiccants, GlaxoSmithKline, Maastricht, MECC Exhibition Centre, Moisture-control, moisture-proof packaging, Netherlands, polyurethane, Ricardo Cremonini, Saul Edwards, sealants, U-Tech 2021, Zeolite
LONDON/ ROTTERDAM, 04-Dec-2018 — /EuropaWire/ — Unilever today announced it has signed an agreement to acquire the Health Food Drinks portfolio (GSK HFD) of GlaxoSmithKline (GSK) in India, Bangladesh and 20 other predominantly Asian markets. The transaction consists of three elements: … Read the full press release
Posted in Business, Food & Beverage, Healthcare, Management, Netherlands, United Kingdom
Tagged acquisition, ASIA, Bangladesh, GlaxoSmithKline, Healthcare, Horlicks, INDIA, MERGER, Nitin Paranjpe, Nutrition, Sanjiv Mehta, Unilever
Brentford, United Kingdom, 17-May-2018 — /EuropaWire/ — GlaxoSmithKline plc (GSK) will present extensive data from across its respiratory portfolio, pipeline and early phase research programmes at the American Thoracic Society (ATS) conference in San Diego, USA, 19-23 May 2018. Data presented … Read the full press release
LONDON, 20-Apr-2018 — /EuropaWire/ — Once-daily single inhaler triple therapy superior to Relvar/Breo Ellipta and Anoro Ellipta across multiple endpoints including exacerbations, lung function and quality of life. GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced the … Read the full press release
NOTTINGHAM, 18-Apr-2017 — /EuropaWire/ — A new and unique smartphone app to help people with asthma manage their condition has been developed by lung experts at the Nottingham Respiratory Research Unit and the pharmaceutical company GlaxoSmithKline (GSK). The MyAsthma app has been launched … Read the full press release
LONDON, 29-Sep-2016 — /EuropaWire/ — GSK today announced that Brian McNamara, is appointed Chief Executive Officer (CEO) of GSK’s Consumer Healthcare division effective immediately. He succeeds Emma Walmsley who was last week appointed GSK CEO Designate succeeding Sir Andrew Witty as … Read the full press release
Posted in Management, Pharma & Biotech, United Kingdom
LONDON, 29-Sep-2016 — /EuropaWire/ — Further to the announcement by GlaxoSmithKline on 28 September 2016, GlaxoSmithKline has agreed to the sale of 28.2 million ordinary shares in Aspen Pharmacare Holdings Ltd (“Aspen”) at a price of ZAR 300 per share (the … Read the full press release
Posted in Business, Healthcare, Investment, Management, Pharma & Biotech, United Kingdom
Tagged Aspen Pharmacare Holdings Ltd, GlaxoSmithKline, Simon Dingemans
LONDON, 29-Sep-2016 — /EuropaWire/ — GlaxoSmithKline announces that it intends to sell its remaining stake in Aspen Pharmacare Holdings Ltd (“Aspen”). The disposal will be through a placing of ordinary shares in Aspen to institutional investors (the “Offering”). The Offering is … Read the full press release
Posted in Business, Healthcare, Investment, Management, Pharma & Biotech, United Kingdom
London / UK, Schindellegi / CH, 13-1-2016 — /EuropaWire/ — Kuehne + Nagel and GSK signed an end-to-end global logistics partnership until 2021 that will see Kuehne + Nagel run the core business of transporting products from the raw materials … Read the full press release
LONDON, 9-10-2014 — /EuropaWire/ — GlaxoSmithKline plc (LSE: GSK) today announced the appointment of Mr Urs Rohner to its Board as a Non-Executive Director, effective 1 January 2015. On appointment, Mr Rohner will also become a member of GSK’s Remuneration … Read the full press release
Posted in Business, Management, Pharma & Biotech, United Kingdom
Tagged GlaxoSmithKline, Sir Christopher Gent, Urs Rohner, Victoria Whyte
London, 29-4-2014 — /EuropaWire/ — GlaxoSmithKline (GSK) and Medicines for Malaria Venture (MMV) today announced the start of a phase III global programme to evaluate the efficacy and safety of tafenoquine, an investigational medicine which is being developed for the treatment and … Read the full press release
London, 29-4-2014 — /EuropaWire/ — GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the European Commission has granted marketing authorisation for Incruse® (umeclidinium) as a once-daily, maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). Now licensed across … Read the full press release
Posted in Business, European Union, Healthcare, Marketing, Pharma & Biotech, United Kingdom
Tagged Chronic obstructive pulmonary disease, Darrell Baker, GlaxoSmithKline, GlaxoSmithKline's Incruse® (umeclidinium) gets European Commission marketing authorisation, Incruse® (umeclidinium), maintenance bronchodilator treatment of COPD
London, UK, 23-10-2013 — /EuropaWire/ — GSK announces Q3 core EPS growth of 16% and dividend of 19p Core EPS 28.9p (+16%) benefiting from operating, financial and long-term cost efficiencies Pharma & Vaccines sales flat: US +2%, Europe +5%, Japan +2% offset by … Read the full press release
Posted in Business, Financial, Healthcare, Investment, Pharma & Biotech, United Kingdom
Tagged FluLaval Q-IV vaccine for flu, GlaxoSmithKline, GSK dividend of 19p (+6%), GSK EPS Q3 2013, GSK pharma sales, GSK Q3 results, GSK vaccines sales, Relvar Ellipta for asthma, Tafinlar for metastatic melanoma, Tivicay for HIV
London, UK, 23-10-2013 — /EuropaWire/ — GlaxoSmithKline plc (LSE:GSK) today announced the submission of a New Drug Application (NDA) in the US for the once daily inhaled corticosteroid (ICS) treatment, fluticasone furoate (FF), administered using the ELLIPTA™ dry powder inhaler. The NDA … Read the full press release
Posted in Government, Healthcare, Pharma & Biotech, Science, United Kingdom
Tagged asthma, Bradd Pavur, Catherine Hartley, David Daley, David Mawdsley, ELLIPTA™, ELLIPTA™ dry powder inhaler, fluticasone furoate (FF), fluticasone furoate monotherapy, Gary Davies, GlaxoSmithKline, GlaxoSmithKline plc, GSK, James Dodwell, Jeff McLaughlin, Juan Carlos Molina, Karen Collins, Kirsty Collins (SRI & CG), LSE:GSK, Lucy Singah, Melinda Stubbee, NDA, New Drug Application (NDA), once daily inhaled corticosteroid (ICS) treatment, Simon Steel, Stephen Rea, Tom Curry, US FDA, US regulatory submission, Ziba Shamsi
London, UK, 23-10-2013 — /EuropaWire/ — ViiV Healthcare today announced the submission of a regulatory application in the United States for its investigational single-tablet regimen (STR) combining dolutegravir, abacavir and lamivudine for the treatment of people living with HIV-1. This New Drug … Read the full press release
Posted in Government, Healthcare, Pharma & Biotech, Science, United Kingdom
Tagged abacavir, antiretroviral agents, David Daley, dolutegravir, Gary Davies, GlaxoSmithKline, GSK, HIV, HIV-1, James Dodwell, Jeff McLaughlin, lamivudine, Lucy Budd, Marc Meachem, Marketing Authorisation Application, Melinda Stubbee, New Drug Application (NDA), people living with HIV, Pfizer, Rebecca Hunt, single-tablet regimen, Tivicay®, Tom Curry, treatment of HIV-1, US Food and Drug Administration (FDA), US regulatory submission, ViiV Healthcare, Ziba Shamsi
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
